FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Instagram Outage Disrupts Thousands of U.S. Users 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
BOULDER, Colo., Nov. 15, 2016 -- CWC Labs, an ISO 17025 accredited science laboratory, is partnering with Native Hemp Solutions (http://www.nativehempsolutions.com) to release the first ISO laboratory-verified cannabinoid hemp extract (with CBD) based on a game-changing mass-spec laboratory analysis method.
CWC Labs director Mike Adams (CWClabs.com) led the science team that developed the mass-spec CBD analysis method using LC-MS-TOF instrumentation. CWC labs is internationally accredited as ISO 17025 compliant. The mass-spec method developed by Adams offers orders of magnitude higher sensitivity than traditional HPLC methods, while simultaneously authenticating cannabinoid molecules using ion fragmentation, isotopic ratio analysis and other analysis techniques.
The ability to quantify cannabinoid molecules such as CBD while simultaneously authenticating their molecular integrity is a first for hemp industry science. The new scientific approach eliminates any possibility of counterfeit cannabinoids and accurately confirms the concentration of CBD, CBD-A and other cannabinoids in each production lot.
The FDA has issued numerous warnings to CBD product manufacturers for failing to accurately quantify the CBD content of their products. "Existing hemp labs are using wildly inaccurate, outdated methods to attempt to quantitate CBD in hemp extracts," said Mike Adams. "Common lab approaches based on HPLC suffer from critical problems in the co-elution of cannabinoids as well as the complete inability to discriminate molecules based on accurate mass and ion fragmentation."
Adams spent more than eight months developing and refining the new mass-spec method, which was developed on an Agilent Time-Of-Flight mass-spec system. He says the method will soon be published in a science paper and shared with the hemp industry. "I aim to help other hemp product companies improve their science and deliver more trusted and accurate products to consumers," Adams said.
Native Hemp Solutions hemp extracts with naturally occurring cannabinoids are available at NativaHempSolutions.com
CWC Labs commercial hemp testing services are available through CWClabs.com.
Media Relations: Lacey M. [email protected]
